What does AIID stand for?

Autoimmune and Inflammatory Disorders

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
American Independent Insurance Company (various locations) American International Insurance Company Aboriginal and Islander Independent Community School (Australia) Artificial Intelligence and Integrated Computer Systems Division (Linkoping University; Sweden) Australian International Institute of Contemporary Singing (Melbourne, Victoria, Australia) Advanced Institute for Information and Communication Technology (South Africa) All India Indira Congress Tiwari (political party) Amsterdam Institute for International Development (est. 2000; Netherlands) Arthritis, Immune and Inflammatory Disorders Association des Infirmiers(ères) Intervenant(e)s en Diabétologie		Anthelmintic Imidazoles Induced Delayed Encephalopathy Applications of Information Integration in Digital Ecosystems (International Workshop) Artificial Intelligence and Interactive Digital Entertainment Acupuncture International Import & Export (France) American Institute of Industrial Engineers Anales del Instituto de Investigaciónes Esteticas (Spanish: Annals of the Institute of Aesthetic Research) Apple IIE (Apple computer) Aqaba International Industrial Estate (Jordan) Associazione Italiana Informatica Etica (Italian: Italian Association of Computer Ethics) Artificial Intelligence in Education

Samples in periodicals archive:

The deal comes as Novo Nordisk beefs up its recently established local research center for autoimmune and inflammatory disorders, a few blocks away from VLST's offices in South Lake Union.

Deal to yield $12M for VLST; Seattle biotech; Company, Danish ...

Peptimmune is a privately held clinical stage biotechnology company focused on the development of peptide therapies to improve the management of chronic autoimmune and inflammatory disorders.

Peptimmune Announces Grant of United States Patent for PI-2301 ...

This history of success has been expanded to disease areas including autoimmune and inflammatory disorders, respiratory disease, metabolic disorders, central nervous system disorders, and age-related conditions.

COLLABORATION CREATES CLINICAL GENOMICS INFRASTRUCTURE

SEATTLE -- Novo Nordisk and VLST Corporation, a Seattle-based biotechnology company focused on the development of therapeutics for autoimmune and inflammatory disorders, today announced that the companies have entered into an exclusive, worldwide collaboration agreement to develop therapeutic targets utilizing VLST's technology platform in the fields of autoimmune and inflammatory disorders.

VLST Corporation and Novo Nordisk Announce Collaboration Agreement to ...

The CD70 antigen is highly expressed on activated T- and B-cells but not resting lymphocytes, and has been associated with a variety of autoimmune and inflammatory disorders.

Seattle Genetics Initiates SGN-70 Phase I Clinical Trial

CD70 is also present on activated T cells, providing a therapeutic opportunity in autoimmune and inflammatory disorders.

Seattle Genetics Announces Advancements in Development Programs at ...

The company applies its core technologies to develop long-acting biopharmaceuticals that may be inhaled or injected less frequently, and to discover novel drugs to treat antibody-mediated autoimmune and inflammatory disorders.

Biovitrum and Syntonix Enter Agreement for the Joint Development and ...

SEATTLE -- VLST Corporation, a Seattle-based biotechnology company focused on the streamlined development of therapeutics for autoimmune and inflammatory disorders, and Accelerator Corporation, an investment vehicle supporting the formation and development of next-generation biotechnology companies, today announced the appointment of Martin A.

VLST Corporation and Accelerator Corporation Name Martin A. Simonetti ...